Long-term control of lung metastasis of tongue cancer treated effectively with cetuximab combination chemotherapy

被引:0
|
作者
Terabe, T. [1 ,2 ]
Ishibashi-Kanno, N. [1 ,3 ]
Uchida, F. [1 ]
Bukawa, H. [1 ]
机构
[1] Univ Tsukuba, Inst Med, Dept Oral & Maxillofacial Surg, Tsukuba, Ibaraki, Japan
[2] Ishioka Daiichi Hosp, Dept Dent & Oral Maxillofacial Surg, Ibaraki, Japan
[3] Univ Tsukuba, Inst Med, Dept Oral & Maxillofacial Surg, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan
关键词
Tongue cancer; Neoplasm metastasis; Cetuximab; Oral squamous cell carcinoma; Head and neck squamous cell carcinoma; SQUAMOUS-CELL CARCINOMA; PLUS CETUXIMAB; 1ST-LINE TREATMENT; HEAD; NECK; CISPLATIN; RADIOTHERAPY; DOCETAXEL;
D O I
10.1016/j.ijom.2023.07.001
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Generally, systemic chemotherapy is indicated for oral squamous cell carcinoma with distant metastasis and has a poor prognosis. Recently, the advent of molecular targeted drugs, such as cetuximab and immune checkpoint inhibitors, has dramatically improved prognosis, though controlling distant metastasis remains challenging. We report a case of tongue cancer in which lung metastases disappeared in the long term. A 60-year-old Japanese male with squamous cell carcinoma of the tongue underwent preoperative chemoradiotherapy and surgery including subtotal glossectomy, bilateral modified radical neck dissection, and immediate reconstruction with an anterolateral thigh flap. One month after surgery, multiple nodules less than 10 mm in diameter appeared in both lungs on CT imaging. Multiple lung metastases were diagnosed with no local recurrence or regional lymph node metastasis. The patient continues to receive a 4-week treatment course of chemotherapy that included cetuximab every 3 months and the lung metastases were markedly reduced in size or had disappeared. No local recurrence or newly emerged metastases were observed. The patient has been doing well for nine years since the appearance of the lung metastases.
引用
收藏
页码:1221 / 1224
页数:4
相关论文
共 50 条
  • [41] Long-term outcomes of differentiated thyroid cancer with only lung metastasis and the prognostic factors
    Choi, Joon Ho
    Moon, Hansol
    Park, Jihyun
    Chang, Kyoungjin
    Byun, Byung Hyun
    Lim, Ilhan
    Kim, Byung Il
    Choi, Chang Woon
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [42] Gastrointestinal metastasis of lung cancer with special emphasis on a long-term survivor after operation
    Min Soo Kim
    Eun Hee Kook
    Se Han Ahn
    Se Young Jeon
    Jung Ho Yoon
    Min Sung Han
    Cheol Hyeon Kim
    Jae Cheol Lee
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 297 - 301
  • [43] Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab
    Szturz, Petr
    Specenier, Pol
    Van Laer, Carl
    Van den Weyngaert, Danielle
    Corthouts, Bob
    Carp, Laurens
    Van Marck, Eric
    Vanderveken, Olivier
    Vermorken, Jan B.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2016, 273 (06) : 1629 - 1636
  • [44] Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab
    Hopkins, Ashley M.
    Kichenadasse, Ganessan
    Karapetis, Chris S.
    Rowland, Andrew
    Sorich, Michael J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [45] Cortical thinning in chemotherapy-treated older long-term breast cancer survivors
    Ebenezer Daniel
    Frank Deng
    Sunita K. Patel
    Mina S. Sedrak
    Heeyoung Kim
    Marianne Razavi
    Can-Lan Sun
    James C. Root
    Tim A. Ahles
    William Dale
    Bihong T. Chen
    Brain Imaging and Behavior, 2023, 17 : 66 - 76
  • [46] LONG-TERM SURVIVORS OF ADVANCED NON-SMALL CELL LUNG-CANCER TREATED WITH COMBINATION CHEMOTHERAPY - QUALITY-OF-LIFE AND FACTORS INFLUENCING RESPONSE TO TREATMENT
    MONK, BJ
    MILLER, TP
    SIGH, C
    CLINICAL RESEARCH, 1986, 34 (01): : A76 - A76
  • [47] Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab
    Petr Szturz
    Pol Specenier
    Carl Van Laer
    Danielle Van Den Weyngaert
    Bob Corthouts
    Laurens Carp
    Eric Van Marck
    Olivier Vanderveken
    Jan B. Vermorken
    European Archives of Oto-Rhino-Laryngology, 2016, 273 : 1629 - 1636
  • [48] Cortical thinning in chemotherapy-treated older long-term breast cancer survivors
    Daniel, Ebenezer
    Deng, Frank
    Patel, Sunita K.
    Sedrak, Mina S.
    Kim, Heeyoung
    Razavi, Marianne
    Sun, Can-Lan
    Root, James C.
    Ahles, Tim A.
    Dale, William
    Chen, Bihong T.
    BRAIN IMAGING AND BEHAVIOR, 2023, 17 (01) : 66 - 76
  • [49] Patients With Breast Cancer Who Are Treated With Chemotherapy Risk Long-Term Nerve Damage
    Printz, Carrie
    CANCER, 2018, 124 (04) : 663 - 663
  • [50] Altered gyrification in chemotherapy-treated older long-term breast cancer survivors
    Daniel, Ebenezer
    Deng, Frank
    Patel, Sunita K.
    Sedrak, Mina S.
    Kim, Heeyoung
    Razavi, Marianne
    Sun, Can-Lan
    Root, James C.
    Ahles, Tim A.
    Dale, William
    Chen, Bihong T.
    BRAIN AND BEHAVIOR, 2024, 14 (08):